InvestmentApr 24, 2026, 04:32 PM
Lucid Diagnostics Closes $18M Public Offering, Netting $16.8M
AI Summary
Lucid Diagnostics Inc. announced the closing of its previously announced underwritten public offering on April 24, 2026. The company successfully sold 18,000,000 shares of its common stock at a price of $1.00 per share. This offering is expected to generate approximately $16.8 million in net proceeds, which the company intends to allocate towards working capital and general corporate purposes.
Key Highlights
- Lucid Diagnostics closed its underwritten public offering on April 24, 2026.
- The company sold 18,000,000 shares of common stock.
- Shares were priced at $1.00 each.
- Net proceeds from the offering are approximately $16.8 million.
- Proceeds will be used for working capital and general corporate purposes.
Price Impact
More from LUCD